AlphaFold开启了蛋白质结构预测的大门，然而，蛋白质不是一成不变的，它的功能性伴随着结构的变化，预测这种变化是AlphaFold还做不到的。《科学》杂志2025年7月10日发表了一篇来自微软研究院的文章，介绍了一个称为BioEmu的深度学习模型 ...

自创立以来，Isomorphic Labs开发出多个新一代AI模型，这些模型共同构成统一的AI药物设计引擎，可应用于多个治疗领域和药物模式。近期，Isomorphic Labs宣布获得6亿美元融资，由Thrive ...

新智元报道 编辑：KingHZ【新智元导读】还在质疑AI生物制药「纸上谈兵」？Chai-2已经把抗体设计成功率从0.1%提升到16%，而且还是零样本！不仅是技术奇迹，这更是范式革命：下一代药神，可能不是生物学博士，而是提示词工程师。AI药神来了？不仅可以零样本生成新抗体，还将成功率提升百倍——达到16%！最近，AI初创Chai ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

A newly developed generative AI model is helping researchers explore protein dynamics with increased speed. The deep learning system, called BioEmu, predicts the full range of conformations a protein ...

BioEmu 的开源发布也标志着微软在推动开放科学方面迈出的重要一步。目前，BioEmu ...

The fusion of wearables with AI is particularly transformative. A UAE-based healthcare entity recently partnered with global ...

谷歌母公司 Alphabet 旗下的 Isomorphic Labs 正准备启动其人工智能设计药物的人体试验。该公司总裁科林·默多克（Colin Murdoch）透露，这家源自 DeepMind 突破性技术 AlphaFold ...

Microsoft’s artificial intelligence tool BioEmu can predict the multiple conformational states of a protein, giving insight into how a protein moves and its potential function.

The start-up, which aims to raise tens of millions of US dollars in an angel funding round, hopes to compete globally, ...

Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.

据外媒报道，美国硅谷巨头字母表公司（Alphabet）旗下公司同构实验室（Isomorphic ...